Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the 42nd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to begin at 10:30 a.m. ET (7:30 a.m. PT) on Wednesday, January 10, 2024.
Related news for (VCEL)
- Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
- Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
- Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
- vericel announces fda approval and commercial availability of maci arthro
- vericel announces fda approval of nexobrid for the treatment of pediatric patients with severe thermal burns